新CAR T细胞疗法在治疗血癌方面很有希望,为抗病提供了希望。 New CAR T-cell therapy shows promise in treating blood cancers, offering hope for resistant cases.

CAR-T细胞治疗是一种新的癌症治疗,它使用病人自己修改过的T细胞来对抗癌症,特别在白血病和淋巴瘤等血癌中显示了希望。 CAR T-cell therapy, a new cancer treatment, uses a patient's own modified T-cells to fight cancer, showing promise especially in blood cancers like leukemia and lymphoma. 对于某些经批准的血癌,它为那些对传统治疗没有反应的人提供了希望,但具有潜在的副作用,如细胞释放综合症。 Approved for certain blood cancers, it offers hope for those unresponsive to traditional treatments but comes with potential side effects like cytokine release syndrome. 研究者旨在扩大对固态肿瘤的使用范围。 Researchers aim to broaden its use to solid tumors. 在印度,两名急性类流质白血病患者成功地进行了异基因干细胞移植,导致其消退。 In India, two patients with acute myeloid leukemia successfully underwent allogeneic stem cell transplants, leading to their remission.